Company Overview

LifeMap Solutions is developing innovative digital health solutions in partnership with the Icahn Institute for Genomics and Multiscale Biology, which is located within the Icahn School of Medicine at Mount Sinai. LifeMap Solutions integrates health and wellness information with care team guidance into a secure mHealth platform to deliver digital health solutions that empower patients to make better choices to achieve optimal health outcomes.

LifeMap Solutions is working with the Icahn Institute for Genomics and Multiscale Biology at Mount Sinai to develop big data analytics algorithms that will process the unprecedented volume of study data, make new discoveries about chronic disease management, and help optimize individual patient care and choices. The partnership will combine the experience of LifeMap Solutions in consumer behavior, app analytics, and design with Mount Sinai’s world-leading expertise in health research. Trends and effects that were invisible at the small scale of traditional asthma research studies can, for the first time, be revealed by large-scale studies the researchers plan to do with the captured patient data.

Our Parent Company

LifeMap Solutions is headquartered in San Jose, California, and is a subsidiary of BioTime, Inc. (NYSE MKT and TASE: BTX).

BioTime, Inc.
BioTime is a clinical-stage biotechnology company engaged in research and product development in the field of regenerative medicine. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. BioTime’s focus is on pluripotent stem cell technology based on human embryonic stem (“hES”) cells and induced pluripotent stem (“iPS”) cells. hES and iPS cells provide a means of manufacturing every cell type in the human body and therefore show considerable promise for the development of a number of new therapeutic products.